A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis

Status:
Completed

Trial end date:
2005-10-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy of Sativex® compared with placebo in reducing the daily number of episodes on incontinence.

Phase 3

GW Pharmaceuticals Ltd.

Dronabinol
Nabiximols